Literature DB >> 25712164

Single-walled carbon nanotubes functionalized with aptamer and piperazine-polyethylenimine derivative for targeted siRNA delivery into breast cancer cells.

Marzieh Mohammadi1, Zahra Salmasi1, Maryam Hashemi2, Fatemeh Mosaffa3, Khalil Abnous4, Mohammad Ramezani5.   

Abstract

Epithelial cell adhesion molecule (EpCAM) is a glycosylated type 1 membrane protein which is frequently over expressed in most solid tumors and it has recently been identified as a cancer stem cell (CSC) marker. Specific targeting of CSCs using nano-carriers would enhance treatment efficacy of cancer. In this study, we used a RNA aptamer against EpCAM (EpDT3) attached physically to our newly synthesized non-viral vector, based on single-walled carbon nanotube (SWNT) conjugated to piperazine-polyethylenimine derivative. The DNA transfection efficiency and siRNA delivery activity of the synthesized vector was investigated against upregulated BCL9l, which has been associated with breast and colorectal cancers. The complexes of the vector-aptamer/siRNA could specifically induce apoptosis by more than 20% in MCF-7 cell line as a positive EpCAM than MDA-MB-231 cells which are EpCAM negative. The decrease of BCL9l protein level was observed with western blot analysis in MCF-7 cells indicating the targeted silencing activity of the complex.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aptamer; Epithelial cell adhesion molecule; Gene delivery; Single-walled carbon nanotube; siRNA

Mesh:

Substances:

Year:  2015        PMID: 25712164     DOI: 10.1016/j.ijpharm.2015.02.031

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  12 in total

Review 1.  Eco-friendly synthesis of carbon nanotubes and their cancer theranostic applications.

Authors:  Ebrahim Mostafavi; Siavash Iravani; Rajender S Varma; Mehrdad Khatami; Fatemeh Rahbarizadeh
Journal:  Mater Adv       Date:  2022-05-16

2.  Coinhibition of overexpressed genes in acute myeloid leukemia subtype M2 by gold nanoparticles functionalized with five antisense oligonucleotides and one anti-CD33(+)/CD34(+) aptamer.

Authors:  M A Zaimy; A Jebali; B Bazrafshan; S Mehrtashfar; S Shabani; A Tavakoli; S H Hekmatimoghaddam; A Sarli; H Azizi; P Izadi; B Kazemi; A Shojaei; A Abdalaian; J Tavakkoly-Bazzaz
Journal:  Cancer Gene Ther       Date:  2016-08-12       Impact factor: 5.987

Review 3.  Nucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical Sensing.

Authors:  Ti-Hsuan Ku; Tiantian Zhang; Hua Luo; Tony M Yen; Ping-Wei Chen; Yuanyuan Han; Yu-Hwa Lo
Journal:  Sensors (Basel)       Date:  2015-07-06       Impact factor: 3.576

Review 4.  Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies.

Authors:  Mohamed I Nounou; Fatema ElAmrawy; Nada Ahmed; Kamilia Abdelraouf; Satyanarayana Goda; Hussaini Syed-Sha-Qhattal
Journal:  Breast Cancer (Auckl)       Date:  2015-09-27

Review 5.  Carbon nanotubes as cancer therapeutic carriers and mediators.

Authors:  Kuk Hui Son; Jeong Hee Hong; Jin Woo Lee
Journal:  Int J Nanomedicine       Date:  2016-10-07

Review 6.  Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and Uses.

Authors:  Panoraia I Siafaka; Neslihan Üstündağ Okur; Evangelos Karavas; Dimitrios N Bikiaris
Journal:  Int J Mol Sci       Date:  2016-08-31       Impact factor: 5.923

Review 7.  Nano-based delivery of RNAi in cancer therapy.

Authors:  Yong Xin; Min Huang; Wen Wen Guo; Qian Huang; Long Zhen Zhang; Guan Jiang
Journal:  Mol Cancer       Date:  2017-07-28       Impact factor: 27.401

Review 8.  Aptamer Hybrid Nanocomplexes as Targeting Components for Antibiotic/Gene Delivery Systems and Diagnostics: A Review.

Authors:  Navid Rabiee; Sepideh Ahmadi; Zeynab Arab; Mojtaba Bagherzadeh; Moein Safarkhani; Behzad Nasseri; Mohammad Rabiee; Mohammadreza Tahriri; Thomas J Webster; Lobat Tayebi
Journal:  Int J Nanomedicine       Date:  2020-06-17

Review 9.  Cancer stem cells and strategies for targeted drug delivery.

Authors:  Jin Cao; Shubhmita Bhatnagar; Jiawei Wang; Xueyong Qi; Swayam Prabha; Jayanth Panyam
Journal:  Drug Deliv Transl Res       Date:  2020-10-23       Impact factor: 5.671

Review 10.  Aptamer-Based Therapeutic Approaches to Target Cancer Stem Cells.

Authors:  Gang Zhou; Olivier Latchoumanin; Mary Bagdesar; Lionel Hebbard; Wei Duan; Christopher Liddle; Jacob George; Liang Qiao
Journal:  Theranostics       Date:  2017-09-13       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.